Clinical Trial Update: AlloGen-LI Treatment of Spinal Stenosis [NA]

View source ↗

Summary

USC-sponsored clinical trial evaluating AlloGen-LI for spinal stenosis has been withdrawn; the listed condition is low back pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• AlloGen-LI

Snippet

Sponsor: University of Southern California | Conditions: Low Back Pain | NA | Status: WITHDRAWN